Search Results

AngioDynamics’ AlphaVac F18⁸⁵ System’s APEX-AV Trial Results Published

January 13, 2025—AngioDynamics, Inc. announced that the results from the APEX-AV trial, which evaluated acute pulmonary embolism (PE) extraction with the company’s AlphaVac F18⁸⁵ system, were published by Mona Ranade, MD, et al online in JSCAI, the Journal of the Society for Cardiovascular Angiography & Interventions.

AngioDynamics Launches APEX-AV Study in Partnership with PERT Consortium

April 27, 2022—AngioDynamics, Inc. announced the launch of APEX-AV, the “Acute Pulmonary Embolism Extraction Trial with the AlphaVac System” clinical study, which is aimed at evaluating the efficacy and safety of the company’s AlphaVac multipurpose mechanical aspiration (MMA) F1885 system in the treatment of acute intermediate-risk pulmonary embolism (PE).

APEX-AV Trial Evaluates AngioDynamics’ AlphaVac F18⁸⁵ Mechanical Thrombectomy System to Treat PE

May 3, 2024—The safety and efficacy results from the APEX-AV trial of acute pulmonary embolism (PE) extraction with the AlphaVac F1885 aspiration system (AngioDynamics, Inc.) demonstrated that catheter-directed mechanical thrombectomy is safe and effective in patients with acute intermediate-risk PE with significant improvement in the right ventricle (RV) function and minimal major adverse events.

AngioDynamics’ AlphaVac F18⁸⁵ System Receives FDA Clearance for Treatment of PE

April 4, 2024—AngioDynamics, Inc. announced FDA 510(k) clearance for the AlphaVac F1885 system for the treatment of pulmonary embolism (PE).

AngioDynamics Completes Enrollment in APEX-AV Acute PE Trial

December 7, 2023—AngioDynamics, Inc. announced the completion of patient enrollment in the APEX-AV trial of acute pulmonary embolism (PE) extraction with the company’s AlphaVac multipurpose mechanical aspiration (MMA) F1885 system.

AngioDynamics Commences APEX-AV Study to Assess AlphaVac F18⁸⁵ System in Treatment of PE

October 31, 2022—AngioDynamics, Inc. announced the enrollment of the first patient in the “Acute Pulmonary Embolism Extraction Trial With the AlphaVac System” (APEX-AV) clinical study at Jacobi Medical Center in New York, New York.